FR2928371B1 - CYSTEINE DERIVATIVE. - Google Patents

CYSTEINE DERIVATIVE.

Info

Publication number
FR2928371B1
FR2928371B1 FR0951288A FR0951288A FR2928371B1 FR 2928371 B1 FR2928371 B1 FR 2928371B1 FR 0951288 A FR0951288 A FR 0951288A FR 0951288 A FR0951288 A FR 0951288A FR 2928371 B1 FR2928371 B1 FR 2928371B1
Authority
FR
France
Prior art keywords
cysteine derivative
cysteine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0951288A
Other languages
French (fr)
Other versions
FR2928371A1 (en
Inventor
Eko Suzuki
Keiji Iwasaki
Yoshinobu Takino
Fumie Futaki
Yusuke Amino
Fumie Okura
Megumi Kaneko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of FR2928371A1 publication Critical patent/FR2928371A1/en
Application granted granted Critical
Publication of FR2928371B1 publication Critical patent/FR2928371B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0951288A 2008-02-28 2009-02-27 CYSTEINE DERIVATIVE. Active FR2928371B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008047718 2008-02-28

Publications (2)

Publication Number Publication Date
FR2928371A1 FR2928371A1 (en) 2009-09-11
FR2928371B1 true FR2928371B1 (en) 2015-06-05

Family

ID=40981902

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0951288A Active FR2928371B1 (en) 2008-02-28 2009-02-27 CYSTEINE DERIVATIVE.

Country Status (2)

Country Link
JP (1) JP5439849B2 (en)
FR (1) FR2928371B1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5378713B2 (en) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 Composition for external use
FR2958845B1 (en) * 2010-04-16 2012-06-01 Clc Technologie NEW DEPIGMENTING COMPOSITIONS
CN102917685B (en) * 2010-05-28 2015-11-25 味之素株式会社 Cysteine derivative
JP5979155B2 (en) * 2011-11-30 2016-08-24 味の素株式会社 Cosmetics containing cysteine derivatives and alcohol
WO2013081192A1 (en) * 2011-11-30 2013-06-06 味の素株式会社 Cosmetic containing cysteine derivative and surfactant
WO2013081147A1 (en) 2011-11-30 2013-06-06 味の素株式会社 Whitening cosmetic
WO2013081146A1 (en) * 2011-11-30 2013-06-06 味の素株式会社 Anti-wrinkle cosmetic
EP3603611B1 (en) 2017-03-24 2024-01-10 Ajinomoto Co., Inc. Skin whitening agent comprising specific d-amino acids
WO2018174286A1 (en) 2017-03-24 2018-09-27 味の素株式会社 Stratum corneum function improving agent
CN115279893A (en) * 2020-03-16 2022-11-01 味之素株式会社 Method for culturing animal cells
WO2022250348A1 (en) * 2021-05-26 2022-12-01 경북대학교 산학협력단 Skin whitening use of cysteine derivative
CN115138482B (en) * 2022-07-06 2024-01-23 中南大学 Targeted inhibition and Cu-Fe-Mo sulphide ore flotation separation method for chalcopyrite and/or pyrite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759770A (en) * 1969-12-19 1971-05-17 Houde Lab THERAPEUTIC COMPOSITION BASED ON CONDENSATION PRODUCTS OF GLYOXYLIC ACID ESTERS WITH AMINOTHIOLS AND PROCESS FOR THE PREPARATION OF THESE CONDENSATION PRODUCTS
DE19711053C2 (en) * 1997-03-03 1999-09-02 Rommelspacher Combination preparation of 2-methyl-thiazolidine-2,4-dicarboxylic acid and paracetamol
JP2000256131A (en) * 1999-03-09 2000-09-19 Kose Corp Tyrosinase production inhibitor and skin lotion containing the same
DE10008159B4 (en) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and / or its physiologically acceptable salts as anticancer agents
JP2006315962A (en) * 2005-05-10 2006-11-24 Geo Co Ltd Cysteine-containing aqueous composition

Also Published As

Publication number Publication date
JP2009227660A (en) 2009-10-08
FR2928371A1 (en) 2009-09-11
JP5439849B2 (en) 2014-03-12

Similar Documents

Publication Publication Date Title
NO2021006I1 (en) Quofenix, delafloxacin
ATE555107T1 (en) 2-AZA-BICYCLO-Ä2,2,1-ÜHEPTAN DERIVATIVES
DK2308877T3 (en) Imidazopyridine-2-one derivatives
BRPI0813707A2 (en) PYRIMIDINYL-PYRIDAZINONE DERIVATIVES
BRPI0809992A2 (en) PYROLOPYRIMIDINE DERIVATIVES
BRPI0913832A2 (en) pyrrolopyridinylpyrimidin-2-ylamine derivatives
BRPI0915064A2 (en) qunoxalinadione derivatives
DK2344471T3 (en) 7-piperidinealkyl-3,4-dihydroquinolone DERIVATIVE
FR2928371B1 (en) CYSTEINE DERIVATIVE.
BRPI0812155A2 (en) spiroindolinone derivatives
IT1392848B1 (en) MOTORCYCLE.
BRPI0812518A2 (en) INDAZOLAMIDE DERIVATIVES
BRPI0814236A2 (en) QUINAZOLINAMIDE DERIVATIVES
UY33125A (en) DIAZA-ESPIRO- [5,5] -UNDECANOS
BRPI0917446A2 (en) acylaminobenzamide derivatives.
DK2275414T3 (en) CYCLOPENTYLACRYLAMIDE DERIVATIVES
BRPI0906714A2 (en) Substituted heteroarylamide oxazepinopyrimidone derivatives.
BRPI0913234A2 (en) thiazolylpiperidine derivatives
BRPI0907108A2 (en) Toothbrush.
BRPI0814718A2 (en) ISOXAZOL-IMIDAZOL DERIVATIVES
BRPI0922652A2 (en) Quinazolinamide derivatives
BRPI1016192A2 (en) soxazole derivatives.
DK2442870T3 (en) PYRAZINOOXAZEPIN derivatives.
ATE534634T1 (en) 2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
BRPI0912716A2 (en) compound.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16